Nomura Asset Management Co. Ltd. Sells 201,836 Shares of UnitedHealth Group Incorporated $UNH

Nomura Asset Management Co. Ltd. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 26.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 566,390 shares of the healthcare conglomerate’s stock after selling 201,836 shares during the quarter. Nomura Asset Management Co. Ltd. owned 0.06% of UnitedHealth Group worth $176,697,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in UNH. Bayforest Capital Ltd grew its holdings in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 50 shares during the period. LFA Lugano Financial Advisors SA acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $25,000. Islay Capital Management LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $31,000. Finally, Nova Wealth Management Inc. increased its position in UnitedHealth Group by 339.1% during the 1st quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after purchasing an additional 78 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $321.44 on Monday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The firm has a market capitalization of $291.17 billion, a PE ratio of 16.78, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The firm has a fifty day simple moving average of $347.65 and a two-hundred day simple moving average of $318.79. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $7.15 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.8%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sanford C. Bernstein raised their target price on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a research report on Wednesday, October 29th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.